Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients

The DRCR.net Protocol T clinical trial assessed the comparative efficacy and safety of anti-VEGF treatments including aflibercept, ranibizumab and bevacizumab in diabetic macular edema (DME). Post -hoc analyse...

Source: BMC Ophthalmology - September 17, 2020 Category: Opthalmology Authors: J. M. Ruiz-Moreno, F. de Andr és-Nogales and I. Oyagüez Tags: Research article Source Type: research